Telehealth education program for patients preparing for major cancer surgery
Implementing Tele-prehabilitation Education Into Cancer Care Pathways
This study tests whether a telehealth education program can help patients getting ready for major lung and abdominal cancer surgeries recover better and avoid breathing problems compared to those who get regular care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 515 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Melbourne Academic / other |
| Locations | 6 sites (New Lambton Heights, New South Wales and 5 other locations) |
| Trial ID | NCT06631872 on ClinicalTrials.gov |
What this trial studies
This trial evaluates the effectiveness of a telehealth-based education program designed to prepare patients for lung and major abdominal cancer surgeries. It compares the outcomes of patients receiving this program to those receiving usual care, focusing on the development of respiratory complications post-surgery. Secondary outcomes include hospital stay duration, recovery, physical function, self-efficacy, and overall quality of life. The study aims to enhance patient understanding and preparedness for surgery, potentially improving surgical outcomes.
Who should consider this trial
Good fit: Ideal candidates are individuals preparing for lung cancer or major abdominal cancer surgery who can provide consent and understand the educational materials in English.
Not a fit: Patients with concurrent malignancies, severe psychiatric disorders, or those unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly reduce respiratory complications and improve recovery for patients undergoing major cancer surgeries.
How similar studies have performed: Other studies have shown promising results with telehealth interventions in surgical preparation, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Preparing for lung cancer (open or video assisted) or major abdominal cancer surgery (e.g. upper GI, hepatobiliary or colorectal, open or video assisted). * Provide consent * Have primary treating surgeon approval * Proficient in English to understand testing, video interventions as well as outcome assessments. Exclusion Criteria: * Concurrent, actively treated other malignancy or history of other malignancy treated within the past year. * Severe or unstable psychiatric, cognitive or substance abuse disorders, such that precludes informed consent or interferes with cooperation with trial requirements or current inpatients. * Current inpatients or incarcerated * Surgery date booked \<7 days from consent
Where this trial is running
New Lambton Heights, New South Wales and 5 other locations
- John Hunter Hospital — New Lambton Heights, New South Wales, Australia (Recruiting)
- Princess Alexandra Hospital — Woolloongabba, Queensland, Australia (Recruiting)
- Launceston General Hospital — Launceston, Tasmania, Australia (Not_yet_recruiting)
- Austin Health — Heidelberg, Victoria, Australia (Recruiting)
- Royal Melbourne Hospital — Melbourne, Victoria, Australia (Recruiting)
- Fiona Stanley Hospital — Perth, Western Australia, Australia (Recruiting)
Study contacts
- Principal investigator: Linda Denehy, B AppSc (Physio), PhD — University of Melbourne
- Study coordinator: Linda Denehy, B AppSc (Physio), PhD
- Email: l.denehy@unimelb.edu.au
- Phone: +61 3 8344 6428
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.